Recent Updates
Recently added Catalysts
BIIB

Statement: Biogen Statement On Qui Tam Settlement

Key Takeaway: Statement: Biogen Statement On Qui Tam Settlement
Price reaction · baseline $197.78 (2022-09-23 close) · 1 other BIIB headline(s) in the window, move may be shared
day 0 close · peak
-1%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.8%
average across 15 past catalysts
Lead asset
Alefacept
Phase 3 · Chronic Plaque Psoriasis

Full Press Release Details

Statement: Biogen Statement On Qui Tam Settlement.
Last updated: Sep 26, 2022